Trial intelligence / Profile preview

Comparison of dienogest versus combined oral contraceptive pills after surgery for advanced endometriosis

IRCT20191011045063N1Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of dienogest in endometriosis (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Pain improvement and Quality of life. Started Mar 2018; status: completed.

02

Drugs

dienogest
03

Conditions

endometriosis

Beyond the preview

Go deeper on IRCT20191011045063N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191011045063N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call